BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1738 related articles for article (PubMed ID: 28117672)

  • 1. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells.
    Miere C; Devito L; Ilic D
    Methods Mol Biol; 2016; 1357():33-44. PubMed ID: 26246353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
    Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production.
    Manzini S; Viiri LE; Marttila S; Aalto-Setälä K
    Stem Cell Rev Rep; 2015 Dec; 11(6):900-8. PubMed ID: 26341105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.
    Vosough M; Ravaioli F; Zabulica M; Capri M; Garagnani P; Franceschi C; Piccand J; Kraus MR; Kannisto K; Gramignoli R; Strom SC
    PLoS One; 2019; 14(4):e0215490. PubMed ID: 31022207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells.
    Afzal MZ; Strande JL
    J Vis Exp; 2015 Jan; (95):52032. PubMed ID: 25650629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells.
    Kimura K; Tsukamoto M; Tanaka M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Sugiura K; Hatoya S
    Stem Cells Dev; 2021 Jan; 30(2):79-90. PubMed ID: 33256572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.
    Fujie Y; Fusaki N; Katayama T; Hamasaki M; Soejima Y; Soga M; Ban H; Hasegawa M; Yamashita S; Kimura S; Suzuki S; Matsuzawa T; Akari H; Era T
    PLoS One; 2014; 9(12):e113052. PubMed ID: 25479600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming.
    Schmitt CE; Morales BM; Schmitz EMH; Hawkins JS; Lizama CO; Zape JP; Hsiao EC; Zovein AC
    Stem Cell Res Ther; 2017 Jun; 8(1):132. PubMed ID: 28583172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
    BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
    Ovchinnikov DA; Sun J; Wolvetang EJ
    Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
    Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
    Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.